Skip to Content
Join the 'Fosamax' group to help and get support from people like you.

Fosamax News

Continuing Treatment Not Beneficial After Five Years of Bisphosphonates

FRIDAY, Dec. 11, 2020 – For women who have received five years of bisphosphonate therapy, hip fracture risk does not differ with continuing treatment for an additional five years versus...

Longer Bisphosphonate Use May Up Atypical Femur Fracture Risk

THURSDAY, Aug. 20, 2020 – Longer duration of bisphosphonate use is associated with an increased risk for atypical femur fracture, according to a study published in the Aug. 20 issue of the New...

Bisphosphonates Safe but May Not Improve Bone Marrow Lesion Volume

FRIDAY, Aug. 14, 2020 – There is no clear benefit of bisphosphonates on bone marrow lesions (BMLs), according to a study published online Aug. 4 in Osteoarthritis and Cartilage. Priyanka Ballal,...

Longer Bisphosphonate Drug Holiday May Up Fracture Risk

FRIDAY, Aug. 7, 2020 – In patients who have previously suffered a vertebral fracture, a longer bisphosphonate (BP) drug holiday is associated with an increased risk for major osteoporotic fractures...

FDA Medwatch Alert: Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer

Includes: Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate), Atelvia (risedronate delayed release), Didronel (etidronate), and Skelid (tiludronate) ISSUE: FDA notified healthcare...

FDA Medwatch Alert: Update on Early Communication: Bisphosphonates marketed as Alendronate (Fosamax, Fosamax Plus D); Etidronate (Didronel); Ibandronate (Boniva); Pamidronate (Aredia); Risedronate (Actonel, Actonel W/Calcium); Tiludronate (Skelid); Zoledronic acid (Recl

[Posted 11/12/2008] FDA issued an update to the Agency's review of safety data regarding the potential increased risk of atrial fibrillation in patients treated with a bisphosphonate drug....

FDA Medwatch Alert: Bisphosphonates (marketed as Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Fosamax, Fosamax+D, Reclast, Skelid, and Zometa)

[Posted 01/07/2008] FDA informed healthcare professionals and patients of the possibility of severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking...

Ask a Question

Want to post your own question to this support group? You'll need to first create an account with Drugs.com (or sign in to your existing account).

Further Information

Related Condition Support Groups

Osteoporosis

Fosamax Patient Information at Drugs.com